{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:41:48Z","timestamp":1790786508842,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0913-4","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:52:04Z","timestamp":1538383924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-6957","authenticated-orcid":false,"given":"Yann","family":"Nadjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lucia","family":"H\u00fctter-Moncada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ayrignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Kaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tranchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Degardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Laurencin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Martzolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Tilikete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Anheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Audoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Deramecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry Dubard","family":"De Gaillarbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foudil","family":"Lamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"Vanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"913_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","volume":"38","author":"MT Vanier","year":"2015","unstructured":"Vanier MT. Complex lipid trafficking in Niemann-pick disease type C. J Inherit Metab Dis. 2015;38:187\u201399.","journal-title":"J Inherit Metab Dis"},{"key":"913_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann-pick disease type C. Orphanet J Rare Dis. 2010;5:16.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, Ramaswami U, Sirrs S, Marfa MP, et al. Consensus clinical management guidelines for Niemann-pick disease type C. Orphanet J Rare Dis. 2018;13:50.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/ajmg.a.31735","volume":"143A","author":"WS Garver","year":"2007","unstructured":"Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, et al. The national Niemann-pick C1 disease database: report of clinical features and health problems. Am J Med Genet A. 2007;143A:1204\u201311.","journal-title":"Am J Med Genet A"},{"key":"913_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, et al. Recommendations for the diagnosis and management of Niemann-pick disease type C: an update. Mol Genet Metab. 2012;106:330\u201344.","journal-title":"Mol Genet Metab"},{"key":"913_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12883-015-0511-1","volume":"15","author":"J Imrie","year":"2015","unstructured":"Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol. 2015;15:257.","journal-title":"BMC Neurol"},{"key":"913_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0022-3476(05)81695-6","volume":"123","author":"DA Kelly","year":"1993","unstructured":"Kelly DA, Portmann B, Mowat AP, Sherlock S, Lake BD. Niemann-pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr. 1993;123:242\u20137.","journal-title":"J Pediatr"},{"key":"913_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2006.05.054","volume":"249","author":"C Iturriaga","year":"2006","unstructured":"Iturriaga C, Pineda M, Fernandez-Valero EM, Vanier MT, Coll MJ. Niemann-pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci. 2006;249:1\u20136.","journal-title":"J Neurol Sci"},{"key":"913_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1399-0004.1988.tb03460.x","volume":"33","author":"MT Vanier","year":"1988","unstructured":"Vanier MT, Wenger DA, Comly ME, Rousson R, Brady RO, Pentchev PG. Niemann-pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet. 1988;33:331\u201348.","journal-title":"Clin Genet"},{"key":"913_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12.","journal-title":"Orphanet J Rare Dis"},{"key":"913_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13023-014-0140-6","volume":"9","author":"H Jahnova","year":"2014","unstructured":"Jahnova H, Dvorakova L, Vlaskova H, Hulkova H, Poupetova H, Hrebicek M, et al. Observational, retrospective study of a large cohort of patients with Niemann-pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years. Orphanet J Rare Dis. 2014;9:140.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymgme.2009.06.009","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Wraith JE, Guffon N, Rohrbach M, Hwu WL, Korenke GC, Bembi B, et al. Natural history of Niemann-pick disease type C in a multicentre observational retrospective cohort study. Mol Genet Metab. 2009;98:250\u20134.","journal-title":"Mol Genet Metab"},{"key":"913_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","volume":"64","author":"MT Vanier","year":"2003","unstructured":"Vanier MT, Millat G. Niemann-pick disease type C. Clin Genet. 2003;64:269\u201381.","journal-title":"Clin Genet"},{"key":"913_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000112178","volume":"13","author":"MT Vanier","year":"1991","unstructured":"Vanier MT, Rodriguez-Lafrasse C, Rousson R, Duthel S, Harzer K, Pentchev PG, et al. Type C Niemann-pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci. 1991;13:307\u201314.","journal-title":"Dev Neurosci"},{"key":"913_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10545-006-0330-z","volume":"29","author":"L Dvorakova","year":"2006","unstructured":"Dvorakova L, Sikora J, Hrebicek M, Hulkova H, Bouckova M, Stolnaja L, et al. Subclinical course of adult visceral Niemann-pick type C1 disease. A rare or underdiagnosed disorder? J Inherit Metab Dis. 2006;29:591.","journal-title":"J Inherit Metab Dis"},{"key":"913_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/gim.2015.25","volume":"18","author":"CA Wassif","year":"2016","unstructured":"Wassif CA, Cross JL, Iben J, Sanchez-Pulido L, Cougnoux A, Platt FM, et al. High incidence of unrecognized visceral\/neurological late-onset Niemann-pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18:41\u20138.","journal-title":"Genet Med"},{"key":"913_CR17","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1212\/WNL.32.11.1295","volume":"32","author":"WT Longstreth Jr","year":"1982","unstructured":"Longstreth WT Jr, Daven JR, Farrell DF, Bolen JW, Bird TD. Adult dystonic lipidosis: clinical, histologic, and biochemical findings of a neurovisceral storage disease. Neurology. 1982;32:1295\u20139.","journal-title":"Neurology"},{"key":"913_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00644787","volume":"401","author":"M Elleder","year":"1983","unstructured":"Elleder M, Jirasek A, Vlk J. Adult neurovisceral lipidosis compatible with Niemann-pick disease type C. Virchows Arch A Pathol Anat Histopathol. 1983;401:35\u201343.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"913_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.45.9.1739","volume":"45","author":"LM Shulman","year":"1995","unstructured":"Shulman LM, David NJ, Weiner WJ. Psychosis as the initial manifestation of adult-onset Niemann-pick disease type C. Neurology. 1995;45:1739\u201343.","journal-title":"Neurology"},{"key":"913_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1176\/jnp.2006.18.2.158","volume":"18","author":"M Walterfang","year":"2006","unstructured":"Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, Lubman DI, et al. The neuropsychiatry of Niemann-pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci. 2006;18:158\u201370.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"913_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awl260","volume":"130","author":"M S\u00e9vin","year":"2007","unstructured":"S\u00e9vin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-pick disease type C. Brain. 2007;130:120\u201333.","journal-title":"Brain"},{"key":"913_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-76148-0_6","volume-title":"Neurometabolic hereditary diseases: diagnosis and treatment. Springer","author":"Y Nadjar","year":"2018","unstructured":"Nadjar Y, Vanier MT. Niemann-pick disease type C. In: Burlina AP, editor. Neurometabolic hereditary diseases: diagnosis and treatment. Springer; 2018. p. 121\u201346."},{"key":"913_CR23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","volume":"78","author":"FA Wijburg","year":"2012","unstructured":"Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, et al. Development of a suspicion index to aid diagnosis of Niemann-pick disease type C. Neurology. 2012;78:1560\u20137.","journal-title":"Neurology"},{"key":"913_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.mcb.2014.10.028","volume":"126","author":"MT Vanier","year":"2015","unstructured":"Vanier MT, Latour P. Laboratory diagnosis of Niemann-pick disease type C: the filipin staining test. Methods Cell Biol. 2015;126:357\u201375.","journal-title":"Methods Cell Biol"},{"key":"913_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","volume":"118","author":"MT Vanier","year":"2016","unstructured":"Vanier MT, Gissen P, Bauer P, Coll MJ, Burlina A, Hendriksz CJ, et al. Diagnostic tests for Niemann-pick disease type C (NP-C): a critical review. Mol Genet Metab. 2016;118:244\u201354.","journal-title":"Mol Genet Metab"},{"key":"913_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","volume":"7","author":"MC Patterson","year":"2017","unstructured":"Patterson MC, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O, et al. Recommendations for the detection and diagnosis of Niemann-pick disease type C: an update. Neurol Clin Pract. 2017;7:499\u2013511.","journal-title":"Neurol Clin Pract"},{"key":"913_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","volume":"71","author":"VM Stein","year":"2012","unstructured":"Stein VM, Crooks A, Ding W, Prociuk M, O'Donnell P, Bryan C, et al. Miglustat improves Purkinje cell survival and alters microglial phenotype in feline Niemann-pick disease type C. J Neuropathol Exp Neurol. 2012;71:434\u201348.","journal-title":"J Neuropathol Exp Neurol"},{"key":"913_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","volume":"99","author":"JE Wraith","year":"2010","unstructured":"Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, et al. Miglustat in adult and juvenile patients with Niemann-pick disease type C: long-term data from a clinical trial. Mol Genet Metab. 2010;99:351\u20137.","journal-title":"Mol Genet Metab"},{"key":"913_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","volume":"98","author":"M Pineda","year":"2009","unstructured":"Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, et al. Miglustat in patients with Niemann-pick disease type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab. 2009;98:243\u20139.","journal-title":"Mol Genet Metab"},{"key":"913_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765\u201372.","journal-title":"Lancet Neurol"},{"key":"913_CR31","unstructured":"Actelion. Miglustat (Zavesca) Summary of Product Characteristics, EMA. (EudraPharm). 2010. \n                    http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000435\/human_med_001171.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d125\n                    \n                  . Accessed 31 Aug 2018."},{"key":"913_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40265-013-0164-6","volume":"74","author":"KA Lyseng-Williamson","year":"2014","unstructured":"Lyseng-Williamson KA. Miglustat: a review of its use in Niemann-pick disease type C. Drugs. 2014;74:61\u201374.","journal-title":"Drugs"},{"key":"913_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00415-016-8051-1","volume":"263","author":"F Sedel","year":"2016","unstructured":"Sedel F, Chabrol B, Audoin B, Kaphan E, Tranchant C, Burzykowski T, et al. Normalisation of brain spectroscopy findings in Niemann-pick disease type C patients treated with miglustat. J Neurol. 2016;263:927\u201336.","journal-title":"J Neurol"},{"key":"913_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13023-015-0377-8","volume":"10","author":"LA Abel","year":"2015","unstructured":"Abel LA, Walterfang M, Stainer MJ, Bowman EA, Velakoulis D. Longitudinal assessment of reflexive and volitional saccades in Niemann-pick type C disease during treatment with miglustat. Orphanet J Rare Dis. 2015;10:160.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-015-0284-z","volume":"10","author":"MC Patterson","year":"2015","unstructured":"Patterson MC, Mengel E, Vanier MT, Schwierin B, Muller A, Cornelisse P, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-pick disease type C: an observational cohort study. Orphanet J Rare Dis. 2015;10:65.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","volume":"10","author":"S Fecarotta","year":"2015","unstructured":"Fecarotta S, Romano A, Della Casa R, Del Giudice E, Bruschini D, Mansi G, et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-pick disease type C. Orphanet J Rare Dis. 2015;10:22.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1172-7-36","volume":"7","author":"B H\u00e9ron","year":"2012","unstructured":"H\u00e9ron B, Valayannopoulos V, Baruteau J, Chabrol B, Ogier H, Latour P, et al. Miglustat therapy in the French cohort of paediatric patients with Niemann-pick disease type C. Orphanet J Rare Dis. 2012;7:36.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR38","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s00415-015-7819-z","volume":"262","author":"EA Bowman","year":"2015","unstructured":"Bowman EA, Walterfang M, Abel L, Desmond P, Fahey M, Velakoulis D. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-pick disease type C patients treated with miglustat. J Neurol. 2015;262:2106\u201314.","journal-title":"J Neurol"},{"key":"913_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","volume":"99","author":"M Pineda","year":"2010","unstructured":"Pineda M, Perez-Poyato MS, O'Callaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-pick disease type C: a case series. Molec Genet Metab. 2010;99:358\u201366.","journal-title":"Molec Genet Metab"},{"key":"913_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13023-014-0176-7","volume":"9","author":"L Abela","year":"2014","unstructured":"Abela L, Plecko B, Palla A, Burda P, Nuoffer JM, Ballhausen D, et al. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-pick type C disease: a retrospective Swiss cohort study. Orphanet J Rare Dis. 2014;9:176.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13023-017-0714-1","volume":"12","author":"C Heitz","year":"2017","unstructured":"Heitz C, Epelbaum S, Nadjar Y. Cognitive impairment profile in adult patients with Niemann pick type C disease. Orphanet J Rare Dis. 2017;12:166.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0883073809344222","volume":"25","author":"MC Patterson","year":"2010","unstructured":"Patterson MC, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, et al. Long-term miglustat therapy in children with Niemann-pick disease type C. J Child Neurol. 2010;25:300\u20135.","journal-title":"J Child Neurol"},{"key":"913_CR43","doi-asserted-by":"crossref","unstructured":"Bonnot O, Kl\u00fcnemann HH, Velten C, Torres Martin JV, Walterfang M. Systematic review of psychiatric signs in Niemann pick disease type C. World J Biol Psychiatry. 2018:1\u201337.","DOI":"10.1080\/15622975.2018.1441548"},{"key":"913_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1212\/WNL.39.8.1040","volume":"39","author":"JK Fink","year":"1989","unstructured":"Fink JK, Filling-Katz MR, Sokol J, Cogan DG, Pikus A, Sonies B, et al. Clinical spectrum of Niemann-pick disease type C. Neurology. 1989;39:1040\u20139.","journal-title":"Neurology"},{"key":"913_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/AUD.0b013e3182a362b8","volume":"35","author":"KA King","year":"2014","unstructured":"King KA, Gordon-Salant S, Yanjanin N, Zalewski C, Houser A, Porter FD, et al. Auditory phenotype of Niemann-pick disease, type C1. Ear Hear. 2014;35:110\u20137.","journal-title":"Ear Hear"},{"key":"913_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jns.2014.12.005","volume":"348","author":"R Iodice","year":"2015","unstructured":"Iodice R, Dubbioso R, Topa A, Ruggiero L, Pisciotta C, Esposito M, et al. Electrophysiological characterization of adult-onset Niemann-pick type C disease. J Neurol Sci. 2015;348:262\u20135.","journal-title":"J Neurol Sci"},{"key":"913_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10162-014-0459-7","volume":"15","author":"KA King","year":"2014","unstructured":"King KA, Gordon-Salant S, Pawlowski KS, Taylor AM, Griffith AJ, Houser A, et al. Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-pick disease, type C. J Assoc Res Otolaryngol. 2014;15:529\u201341.","journal-title":"J Assoc Res Otolaryngol"},{"key":"913_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/jnnp.74.4.528","volume":"74","author":"KA Josephs","year":"2003","unstructured":"Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry. 2003;74:528\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"913_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1750-1172-9-65","volume":"9","author":"O Bonnot","year":"2014","unstructured":"Bonnot O, Kl\u00fcnemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis. 2014;9:65.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR50","first-page":"133","volume-title":"Handbook of clinical neurology","author":"MT Vanier","year":"1996","unstructured":"Vanier MT, Suzuki K. Niemann-pick disease. In: Moser HW, editor. Handbook of clinical neurology. Amsterdam: Elsevier; 1996. p. 133\u201362."},{"key":"913_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00415-013-7159-9","volume":"261","author":"M Anheim","year":"2014","unstructured":"Anheim M, Lagha-Boukbiza O, Fleury-Lesaunier MC, Valenti-Hirsch MP, Hirsch E, Gervais-Bernard H, et al. Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-pick C disease. J Neurol. 2014;261:174\u20139.","journal-title":"J Neurol"},{"key":"913_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-8-35","volume":"8","author":"M Stampfer","year":"2013","unstructured":"Stampfer M, Theiss S, Amraoui Y, Jiang X, Keller S, Ory DS, et al. Niemann-pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis. 2013;8:35.","journal-title":"Orphanet J Rare Dis."},{"key":"913_CR53","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10072-018-3314-5","volume":"39","author":"S Tozza","year":"2018","unstructured":"Tozza S, Dubbioso R, Iodice R, Topa A, Esposito M, Ruggiero L, et al. Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-pick disease type C: a case report. Neurol Sci. 2018;39:1015\u20139.","journal-title":"Neurol Sci"},{"key":"913_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-7-76","volume":"7","author":"M Walterfang","year":"2012","unstructured":"Walterfang M, Chien YH, Imrie J, Rushton D, Schubiger D, Patterson MC. Dysphagia as a risk factor for mortality in Niemann-pick disease type C: systematic literature review and evidence from studies with miglustat. Orphanet J Rare Dis. 2012;7:76.","journal-title":"Orphanet J Rare Dis."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0913-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0913-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0913-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T23:04:26Z","timestamp":1569884666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0913-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["913"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0913-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Local ethics committee approval of the study was obtained from the CPP \u2013 Ile-de-France.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YN received speech honoraria from Actelion and Orphan Europe; and received travel funding from Actelion, Shire and Genzyme. PL has received presentation honoraria from Actelion Pharmaceuticals France. CG received from Actelion honorarium for participation in an advisory board and funding for inscriptions and travels for congresses. MA declares honoraria from Actelion, Abbvie and Teva. ER received research support from Merz-Pharma, Orkyn, Aguettant, IP Sant\u00e9, Ultragenix, and UCB pharma; served on scientific advisory boards for Orkyn, Ultragenix, Retrophin and Merz-Pharma; received speech honoraria from Orkyn, Aguettant, Merz-Pharma and Ultragenix; and received travel funding from the Elivie, the Dystonia Coalition, the Dystonia Medical Research Foundation, the Movement Disorders Society, the European Academy of Neurology. MTV has received honoraria and travel reimbursement from Actelion Pharmaceuticals Ltd., Sucampo Pharmaceuticals Inc. and Mallinckrodt Pharmaceuticals as a member of advisory committees and\/or guest speaker, travel reimbursement from Vtesse, and honoraria from Shire as a member of a data and safety monitoring board. BH has received travel expenses from, and attended meetings funded and organized by Actelion Pharmaceuticals Ltd., Biomarin, Genzyme Corporation and Shire HGT, and has received presentation honoraria from Actelion Pharmaceuticals Ltd. ALHM, XA, CT, PC, AD, CL, LM, CT, BA, VD, TDdG, and FL have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"175"}}